Marksans Pharma informs about press release

19 Mar 2025 Evaluate
Marksans Pharma has informed that its wholly owned subsidiary Relonchem has received Marketing Authorization for the product Baclofen 10 mg Tablets from UK MHRA.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

221.70 -0.65 (-0.29%)
01-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.95
Dr. Reddys Lab 1152.40
Cipla 1444.55
Lupin 1956.40
Zydus Lifesciences 877.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...